Sutent (sunitinib malate capsules - Pfizer; generic) — Cigna
Thyroid Carcinoma, Medullary
Initial criteria
- Patient age ≥ 18 years
- Patient has tried at least one systemic therapy (e.g., Caprelsa [vandetanib tablets], Cometriq [cabozantinib capsules], Retevmo [selpercatinib capsules], or Gavreto [pralsetinib capsules])
Approval duration
1 year